2022
DOI: 10.1016/j.arabjc.2022.104302
|View full text |Cite
|
Sign up to set email alerts
|

Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 162 publications
0
8
0
Order By: Relevance
“…A mixed standard solution containing adenosine (1), phellodendrine (2), mangnoflorine (3), β-ecdysterone (4), 25R-inokosterone (5), 25S-inokosterone (6), jatrorrhizine (7), palmatine (8), Chikusetsu saponin IVa (9), limonin (10), atractylenolide III (11), atractylenolide I (12), obacunone (13), and atractylenolide II (14) was prepared. Working standard solutions at different concentrations (0.0131-1.9258 μg/mL (1); 0.5270-12.6262 μg/mL (2); 2.2061-42.7327 μg/mL (3); 0.7365-9.0860 μg/mL (4); 0.1399-1.9082 μg/mL (5); 0.1685-2.4206 μg/mL (6); 0.3087-6.4808 μg/mL (7); 0.0594-3.8903 μg/mL (8); 0.5640-7.0554 μg/mL (9); 4.3547-62.9886 μg/mL (10); 0.2168-3.0946 μg/mL (11); 0.1483-2.0170 μg/mL (12); 2.5536-36.1744 μg/mL (13); and 0.2174-3.1473 μg/mL (14)) were prepared in 75% methanol.…”
Section: Quantitative Working Standard Solutions Preparationmentioning
confidence: 99%
See 1 more Smart Citation
“…A mixed standard solution containing adenosine (1), phellodendrine (2), mangnoflorine (3), β-ecdysterone (4), 25R-inokosterone (5), 25S-inokosterone (6), jatrorrhizine (7), palmatine (8), Chikusetsu saponin IVa (9), limonin (10), atractylenolide III (11), atractylenolide I (12), obacunone (13), and atractylenolide II (14) was prepared. Working standard solutions at different concentrations (0.0131-1.9258 μg/mL (1); 0.5270-12.6262 μg/mL (2); 2.2061-42.7327 μg/mL (3); 0.7365-9.0860 μg/mL (4); 0.1399-1.9082 μg/mL (5); 0.1685-2.4206 μg/mL (6); 0.3087-6.4808 μg/mL (7); 0.0594-3.8903 μg/mL (8); 0.5640-7.0554 μg/mL (9); 4.3547-62.9886 μg/mL (10); 0.2168-3.0946 μg/mL (11); 0.1483-2.0170 μg/mL (12); 2.5536-36.1744 μg/mL (13); and 0.2174-3.1473 μg/mL (14)) were prepared in 75% methanol.…”
Section: Quantitative Working Standard Solutions Preparationmentioning
confidence: 99%
“…Because the content of the components in SMP exhibit a considerable rang of difference, the traditional detection methods cannot detect multiple active components in different level at the same time. The UHPLC-QqQ-MS/MS can address this issue with its high sensitivity, excellent selectivity, and a wide dynamic range [13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…Compound formulas consisting of two or more drugs are the most common form of TCM in clinical settings [2]. Synergistic and antagonistic effects are known to occur among the drugs in compound formulas, which can result in a medicine with stronger curative effects or lower toxicity, than the individual drugs [3]. Quality control ensures the efficacy and safety of TCM in clinical use, and elucidating the chemical composition is often a prerequisite before researching the pharmacology and establishing the quality standards.…”
Section: Introductionmentioning
confidence: 99%
“…However, there is no quality-grade research. Based on TCMRD [12,13] and network pharmacology [14,15] of TCM, we propose a relatively accurate evaluation system by combining TCMRD with network pharmacology, which is a recognized tool for confirming functional components related to efficacy. The main process is to prepare TCMRD, establish chemical evaluation methods, conduct network pharmacological analysis on the selected index components, determine the target-focused compounds, and carry out a more comprehensive quality evaluation.…”
Section: Introductionmentioning
confidence: 99%